本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

1.48
+0.10007.25%
成交量:376.66万
成交额:548.80万
市值:1.26亿
市盈率:-2.22
高:1.50
开:1.42
低:1.41
收:1.38
数据加载中...
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/26

重要事件披露

8-K - Current report
2020/10/23

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/09/22

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/29

重要事件披露

8-K - Current report
2020/07/23

重要事件披露

8-K - Current report
2020/07/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]